Previous studies have shown that adipokines such as adiponectin can induce cell apoptosis and enhance the effects of DOX in breast cancer [37, 38] while leptin and resistin can decrease cancer cell apoptosis and reduce the efficacy of DOX [39, 40]. Here, ADIPOQ is linked to breast carcinoma.